Navigation Links
Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
Date:10/28/2009

e extensive expertise in the field of hydroxyethyl starch ("HES") that Fresenius Kabi has gathered as the world's largest producer of pharmaceutical grade HES. HES is derived from waxy maize starch and can be metabolized by the body's enzymes. HES solutions have been safely administered for over 30 years to treat deficient blood volume and to improve the rheological properties of blood.

HESylation® Technology allows a targeted modification of drugs and their characteristics by a site-specific coupling to HES molecules. This can modify key pharmacological parameters such as absorption, metabolization, half-life, water solubility and safety.

HESylation® Technology is covered by a broad portfolio of intellectual property rights. For further details please visit http://www.HESylation.com.

About Octapharma Group

The Octapharma Group is an independent, Swiss-based biopharmaceutical company operating worldwide. Octapharma's core business is the development, production, and sale of high-quality human proteins for the treatment of life-threatening diseases.

The Group has more than 3,500 employees in 28 countries, and owns five modern, state-of-the-art production facilities in Austria, France, Germany, Sweden, and Mexico, respectively. Sales turnover in 2008 reached Euro 886 million with an EBIT of Euro 256 million.

For more information about Octapharma Group please visit the company's website: www.octapharma.com

Fresenius Kabi

Fresenius Kabi is focused on products for the therapy and care of critically and chronically ill patients in and outside the hospital. Fresenius Kabi's core product range includes infusion solutions for fluid substitution, blood volume substitution and intravenously administered drugs as well as parentera
'/>"/>

SOURCE Octapharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
2. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
3. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
4. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
5. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
9. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
10. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
11. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... support, China,s orthopedic instrument industry ... market size rising from 3.28 billion yuan in 2006 ...
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... received commitments from institutional investors to purchase an aggregate ... in an at-the-market registered direct offering, led by a ... into definitive purchase agreements with these investors pursuant to ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... of Higher Doses to Further Reduce Antibodies,to ... /PRNewswire-FirstCall/ -- La Jolla,Pharmaceutical Company today announced ... placebo-controlled,randomized Phase 3 trial of Riquent(R) (abetimus ... ("lupus" or "SLE").,Analyses of interim antibody data ...
... Animal Data Shows Prolonged Survival AND ... 2007 /PRNewswire-FirstCall/ --,ImmuneRegen BioSciences, a wholly-owned ... today that ongoing analysis of,data acquired ... has,revealed evidence that ImmuneRegen's developmental stage ...
Cached Medicine Technology:La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 7IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation 2IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation 3IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation 4IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation 5
(Date:4/22/2014)... April 22, 2014: The Association for Molecular Pathology ... Journal of Molecular Diagnostics on recommendations for ... and master,s levels of education. The report was ... Task Force of the AMP Training and Education ... need of educating future medical laboratory scientists appropriately ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... This news release is available in German . ... species are important intracellular signaling molecules, but their mode ... key aspects of cellular function and behavior, while at ... organelles, membranes and DNA. To analyze how redox signaling ... innovative optical microscopy technique has been developed jointly by ...
(Date:4/22/2014)... help rein in massive health care spending, a new ... find ways to incentivize pharmaceutical companies and device makers ... of examining existing medical technologies and their use, a ... what drugs and medical devices get created in the ... care spending with as little loss of health as ...
(Date:4/22/2014)... we all seem to know who we say is neurotic ... isn,t unable to act but simply doesn,t want to., ... study of nearly 4,000 college students in 19 countries has ... decisions and moving forward with life. Turns out that when ... just don,t like it as much as non-neurotics. Therefore persuasive ...
Breaking Medicine News(10 mins):Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:Neuroimaging: Live from inside the cell 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:Neurotics don't just avoid action: They dislike it 2
... R.I. [Brown University] -- Two years ago, Brown ... of the cancer-suppressing protein p53 and you can ... the same team reports an intriguing follow-up finding. ... lifespan-extending magic in only 14 insulin-producing cells in ...
... -- (Sept. 18, 2007) -- Biomedical engineers at The ... Houston have announced pre-clinical test results in the September ... feasibility of a smart particle insulin release system that ... releases insulin to counteract them. , Designed to mimic ...
... Sept. 20, 2007 Defects on cell-surface sugars may ... in the central nervous system of multiple sclerosis patients, ... findings also suggest that a dietary supplement similar to ... correct these defects and to treat both the short-term ...
... the University of California, San Diego (UCSD) School of ... function of one of the key proteins in all ... plays an essential role in memory formation, communication between ... called x-ray crystallography, the scientists solved the structure of ...
... scientists say , THURSDAY, Sept. 20 (HealthDay News) -- Analyzing ... identify patients with the worst cases of multiple myeloma, U.S. ... noted the team from the Myeloma Institute for Research and ... Multiple myeloma is a cancer that affects the blood plasma ...
... 20 Lehman Millet Incorporated, the,leading medical ... appointment of key hires into its strategy, ... agency attributes this steady,staff expansion to client ... as new,business assignments. Lee Stayton joins ...
Cached Medicine News:Health News:Key to longer life (in flies) lies in just 14 brain cells 2Health News:Smart insulin nanostructures pass feasibility test, UT study reports 2Health News:Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients 2Health News:UCSD study reveals the regulatory mechanism of key enzyme 2Health News:Gene Test Could Boost Myeloma Treatment 2Health News:LehmanMillet Continues Expansion with Strategic Hires 2Health News:LehmanMillet Continues Expansion with Strategic Hires 3
The Trans-Blot transfer cell, used with the included PowerPac 200 power supply, performs efficient, high-intensity electrophoretic transfers. The Trans-Blot cell offers many advantages....
... specifically designed to work with the EC120 ... a small tank blotter that incorporates the ... buffer requirements and fast transfer rates), with ... blotting such as arcing and buffer depletion. ...
... Semi-Dry Blotting System. 20cm x ... Southern gels reliably and quickly. The ... are durable and corrosion free. These ... excellent transfers. Also available in 35cm ...
... SD semi-dry transfer cell allows ... Using a platinum-coated titanium plate ... stainless steel plate as the ... transfers in a horizontal configuration ...
Medicine Products: